CSI Market
Sign In | Register

Tourmaline Bio Inc (TRML) Annual Balance Sheets

Annual · GAAP · USD millions
Access TRML quarterly Balance Sheets →
Looking at balance sheet data from Tourmaline Bio Inc through provides insight into Dec 31 2024's solvency and capital structure over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TRML/balance-sheets
https://api.csimarket.com/api/v1/companies/TRML/fundamentals
https://api.csimarket.com/api/v1/companies/TRML/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent30.51
Combined Cash+Investments Total (filer-reported)294.90
Available-for-sale Securities, Debt Securities, Current MA227.80
Cash & Short-term Investments257.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current10.54
Total Current Assets268.84
Equipment/Property/Plant Net0.06
Long-term investments36.63
Other Assets, Noncurrent5.00
Operating Lease Right Of Use Asset0.21
Total Assets309.00
Liabilities
Accounts Payable, Current AC3.58
Accrued Liabilities, Current AC5.10
Other Liabilities, Current0.23
Total Current Liabilities8.91
Total Long-term Debt0.00
Other liabilities, Noncurrent0.04
Operating Lease Liability Current0.23
Share Repurchase Liability-
Operating Lease Liability Noncurrent0.02
Total Liabilities8.95
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock435.01
Retained Earnings / Accumulated Deficit-135.26
Other Equity0.30
Common Stockholder's Equity300.05
Total Stockholder's Equity300.05
Liabilities & Stockholder's Equity309.00
4 historic quarters locked

Sign in to unlock the full Tourmaline Bio Inc balance sheet history.

Sign In Create Free Account

About Tourmaline Bio Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001827506-25-000027

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI